JP2010502187A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010502187A5 JP2010502187A5 JP2009526792A JP2009526792A JP2010502187A5 JP 2010502187 A5 JP2010502187 A5 JP 2010502187A5 JP 2009526792 A JP2009526792 A JP 2009526792A JP 2009526792 A JP2009526792 A JP 2009526792A JP 2010502187 A5 JP2010502187 A5 JP 2010502187A5
- Authority
- JP
- Japan
- Prior art keywords
- canis
- ifa
- sensitivity
- infections
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000605312 Ehrlichia canis Species 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 9
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- 101710124413 Portal protein Proteins 0.000 description 7
- 101710083205 SAR-endolysin Proteins 0.000 description 7
- 101710092804 Tail tube protein gp19 Proteins 0.000 description 7
- 101800000385 Transmembrane protein Proteins 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 241000282465 Canis Species 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000005875 antibody response Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 241000605282 Ehrlichia ewingii Species 0.000 description 1
- 108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 1
- 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
- 101710164702 Major outer membrane protein Proteins 0.000 description 1
- 241001468109 Neorickettsia Species 0.000 description 1
- 108010008038 Synthetic Vaccines Proteins 0.000 description 1
- 208000035056 Tick-Borne disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000011997 immunoflourescence assay Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84146506P | 2006-08-31 | 2006-08-31 | |
| US60/841,465 | 2006-08-31 | ||
| PCT/US2007/075343 WO2008112007A1 (en) | 2006-08-31 | 2007-08-07 | Immunoreactive glycoprotein gp19 of ehrlichia canis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013257840A Division JP5837917B2 (ja) | 2006-08-31 | 2013-12-13 | エーリキア・カニスの免疫反応性糖タンパク質ｇｐ１９ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010502187A JP2010502187A (ja) | 2010-01-28 |
| JP2010502187A5 true JP2010502187A5 (enExample) | 2013-02-21 |
| JP5498164B2 JP5498164B2 (ja) | 2014-05-21 |
Family
ID=39596493
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009526792A Active JP5498164B2 (ja) | 2006-08-31 | 2007-08-07 | エーリキア・カニスの免疫反応性糖タンパク質ｇｐ１９ |
| JP2013257840A Active JP5837917B2 (ja) | 2006-08-31 | 2013-12-13 | エーリキア・カニスの免疫反応性糖タンパク質ｇｐ１９ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013257840A Active JP5837917B2 (ja) | 2006-08-31 | 2013-12-13 | エーリキア・カニスの免疫反応性糖タンパク質ｇｐ１９ |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9605032B2 (enExample) |
| EP (1) | EP2064231B2 (enExample) |
| JP (2) | JP5498164B2 (enExample) |
| AU (1) | AU2007348944B2 (enExample) |
| CA (1) | CA2662246C (enExample) |
| ES (1) | ES2397548T5 (enExample) |
| WO (1) | WO2008112007A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2604855C (en) | 2005-04-04 | 2016-11-01 | Idexx Laboratories, Inc. | Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| US7842474B2 (en) | 2005-04-04 | 2010-11-30 | Idexx Laboratories, Inc. | Ehrlichia canis DIVA (differentiate infected from vaccinated animals) |
| US9605032B2 (en) * | 2006-08-31 | 2017-03-28 | Research Development Foundation | Immunoreactive glycoprotein GP19 Ehrlichia canis |
| US8784828B2 (en) | 2007-05-04 | 2014-07-22 | The Ohio State University Research Foundation | Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| US7964366B2 (en) * | 2007-09-21 | 2011-06-21 | Idexx Laboratories, Inc. | Methods and compositions for detection of Ehrlichia chaffeensis (VLPT) |
| WO2009059170A2 (en) | 2007-10-31 | 2009-05-07 | Idexx Laboratories, Inc. | Ehrlichia canis diva (differentiate infection from vaccinated animals) |
| GB2467529B (en) | 2009-01-30 | 2013-03-06 | Hughes Safety Showers Ltd | Frame for a shelter |
| EP2424880B1 (en) | 2009-04-28 | 2016-07-20 | Research Development Foundation | Immunoreactive ehrlichia p120/p140 epitopes and uses thereof |
| US20140162256A1 (en) | 2011-03-31 | 2014-06-12 | Yasuko Rikihisa | Compositions and methods for the detection of anaplasma platys |
| EP2925352B1 (en) | 2012-12-03 | 2019-10-02 | Ohio State Innovation Foundation | Ehrlichial invasin for immunization, diagnosis, and cell delivery |
| EP3830105A4 (en) | 2018-07-27 | 2022-07-27 | Research Development Foundation | CHIMERA IMMUNOGENIC POLYPEPTIDES |
| US20220356231A1 (en) * | 2019-07-12 | 2022-11-10 | Research Development Foundation | Ehrlichia vaccines and immunogenic compositions |
| US12226468B2 (en) | 2023-06-26 | 2025-02-18 | Research Development Foundation | Immunoreactive peptides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355777B1 (en) * | 2000-04-28 | 2002-03-12 | Research Development Foundation | P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof |
| CA2604855C (en) * | 2005-04-04 | 2016-11-01 | Idexx Laboratories, Inc. | Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| US9605032B2 (en) * | 2006-08-31 | 2017-03-28 | Research Development Foundation | Immunoreactive glycoprotein GP19 Ehrlichia canis |
-
2007
- 2007-08-07 US US12/377,926 patent/US9605032B2/en active Active
- 2007-08-07 WO PCT/US2007/075343 patent/WO2008112007A1/en not_active Ceased
- 2007-08-07 EP EP07873953.9A patent/EP2064231B2/en active Active
- 2007-08-07 JP JP2009526792A patent/JP5498164B2/ja active Active
- 2007-08-07 CA CA2662246A patent/CA2662246C/en active Active
- 2007-08-07 ES ES07873953T patent/ES2397548T5/es active Active
- 2007-08-07 AU AU2007348944A patent/AU2007348944B2/en active Active
-
2013
- 2013-12-13 JP JP2013257840A patent/JP5837917B2/ja active Active
-
2015
- 2015-06-03 US US14/729,758 patent/US9605033B2/en active Active
-
2017
- 2017-02-27 US US15/443,611 patent/US9814768B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010502187A5 (enExample) | ||
| KR101848194B1 (ko) | Csfv 항체에 대한 개선된 진단 시험 | |
| AU2013329025B2 (en) | Peptides, devices, and methods for the detection of Ehrlichia antibodies | |
| RU2019113127A (ru) | REP белок в качестве белкового антигена для диагностических анализов | |
| RU2018103933A (ru) | Моноклональные антитела, с ориентировкой на антиген Р респираторно-синцитиального вируса человека, получаемые и секретируемые из клеточных гибридом, используемые для обнаружения и диагностики инфекции, вызываемой респираторно-синцитиальным вирусом | |
| ES2647764T3 (es) | Diagnósticos de vacunación mejorados | |
| US11204351B2 (en) | Compositions and methods for identifying Ehrlichia species | |
| US10598660B2 (en) | Application of anaplasma phagocytophilum protein APH1384 | |
| WO2016019244A1 (en) | Bovine herpesvirus detection and treatment | |
| US9915662B2 (en) | Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients | |
| US20220341928A1 (en) | Diagnosis of babesia using babesia recombinant proteins | |
| US20220229055A1 (en) | Species-specific antigen sequences for tick-borne relapsing fever (tbrf) and methods of use | |
| EP2713161A1 (en) | Method of detection of Schmallenberg virus (SBV) and kit | |
| Cho KiHyun et al. | Use of hydrophilic extra-viral domain of canine distemper virus H protein for enzyme-linked immunosorbent assay development. | |
| NZ724911B2 (en) | Compositions and methods for identifying ehrlichia species |